Recombinant CDC42 antibody
Quick Overview for Recombinant CDC42 antibody (ABIN7609540)
Target
See all CDC42 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    - 
                                            Expression System
- HEK-293F Cells
- 
                                            Purpose
- Cdc42 Recombinant Antibody
- 
                                            Characteristics
- The Cdc42 Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC.
- 
                                            Purification
- Affinity-Chromatography
- 
                                            Immunogen
- A Synthesized Peptide Derived From Human Cdc42
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working dilution should be determined by the investigator.
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- Rabbit IgG in Phosphate Buffered Saline, pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol
- 
                                            Storage
- 4 °C,-20 °C
- 
                                            Storage Comment
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
- 
                                            Expiry Date
- 12 months
 
- 
                                            
- 
    - CDC42 (Cell Division Cycle 42 (GTP Binding Protein, 25kDa) (CDC42))
- 
                                            Alternative Name
- CDC42
- 
                                            UniProt
- P60953
- 
                                            Pathways
- MAPK Signaling, Microtubule Dynamics, RTK Signaling, WNT Signaling, TCR Signaling, EGFR Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Maintenance of Protein Location, Skeletal Muscle Fiber Development, Signaling Events mediated by VEGFR1 and VEGFR2, EGFR Downregulation, VEGF Signaling
 Target
- 
                    
 
                                     
                                     
                                    